Locations
Seattle, WA, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series B
founded in
2014
Tasso, Inc. is transforming blood collection with its innovative devices that allow patients to collect their own blood samples at home, eliminating the need for painful needles and phlebotomy. Their products, such as the Tasso+ and Tasso-M20 devices, are designed for ease of use and are supported by a comprehensive logistics platform that ensures samples are shipped to labs for analysis. Tasso's approach enhances patient experience and engagement, making it a leader in decentralized clinical trials and home diagnostics. The company has been cited in over 100 peer-reviewed publications, showcasing its impact in the healthcare sector.
Is this your company?
Something looks off?
On-site & Remote
